OpenURL Connection Search

Select item for more details and to access through your institution.

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.
Published in:
2021
By:
- Kumar, Anita;
- Bantilan, K.S.;
- Jacob, A.P.;
- Park, A.;
- Schoninger, S.F.;
- Sauter, C.;
- Ulaner, G.A.;
- Casulo, C.;
- Faham, M.;
- Kong, K.A.;
- Grewal, R.K.;
- Gerecitano, J.;
- Hamilton, A.;
- Hamlin, P.;
- Matasar, M.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.S.;
- Younes, A.
Publication type:
journal article
IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 152, doi. 10.1002/hon.109_2629
By:
- Batlevi, C.L.;
- Sha, F.;
- Alperovich, A.;
- Ni, A.;
- Smith, K.;
- Ying, Z.;
- Hamlin, P.;
- Horwitz, S.M.;
- Kumar, A.;
- Matasar, M.;
- Moskowitz, A.J.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.;
- Straus, D.;
- Boccomini, C.;
- Tucci, A.;
- Zelenetz, A.D.;
- Seshan, V.E.
Publication type:
Article
PHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF >4 YEARS OF FOLLOW‐UP.
Published in:
Hematological Oncology, 2019, v. 37, p. 296, doi. 10.1002/hon.106_2630
By:
- Zinzani, P.L.;
- Armand, P.;
- Ribrag, V.;
- Michot, J.;
- Kuruvilla, J.;
- Zhu, Y.;
- Farooqui, M.;
- Nahar, A.;
- Moskowitz, C.H.
Publication type:
Article
PHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF >4 YEARS OF FOLLOW‐UP.
Published in:
Hematological Oncology, 2019, v. 37, p. 296, doi. 10.1002/hon.106_2630
By:
- Zinzani, P.L.;
- Armand, P.;
- Ribrag, V.;
- Michot, J.;
- Kuruvilla, J.;
- Zhu, Y.;
- Farooqui, M.;
- Nahar, A.;
- Moskowitz, C.H.
Publication type:
Article
IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 152, doi. 10.1002/hon.109_2629
By:
- Batlevi, C.L.;
- Sha, F.;
- Alperovich, A.;
- Ni, A.;
- Smith, K.;
- Ying, Z.;
- Hamlin, P.;
- Horwitz, S.M.;
- Kumar, A.;
- Matasar, M.;
- Moskowitz, A.J.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.;
- Straus, D.;
- Boccomini, C.;
- Tucci, A.;
- Zelenetz, A.D.;
- Seshan, V.E.
Publication type:
Article
A PHASE I STUDY OF IBRUTINIB COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 265, doi. 10.1002/hon.2438_135
By:
- Sauter, C.S.;
- Matasar, M.J.;
- Schoder, H.;
- Drullinsky, P.;
- Gerecitano, J.;
- Kumar, A.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.S.;
- Straus, D.J.;
- Zelenetz, A.D.;
- McCall, S.S.;
- Miller, S.T.;
- Courtien, A.I.;
- Younes, A.;
- Moskowitz, C.H.
Publication type:
Article
INTERIM RESULTS FROM a PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 85, doi. 10.1002/hon.2437_73
By:
- Herrera, A.F.;
- Moskowitz, A.J.;
- Bartlett, N.L.;
- Vose, J.M.;
- Ramchandren, R.;
- Feldman, T.A.;
- Lacasce, A.S.;
- Ansell, S.M.;
- Moskowitz, C.H.;
- Fenton, K.;
- Ogden, C.;
- Taft, D.;
- Zhang, Q.;
- Kato, K.;
- Campbell, M.;
- Advani, R.H.
Publication type:
Article
DOSE AND/OR VOLUME REDUCTION USING CONSOLIDATION VOLUME RADIATION THERAPY ( CVRT) LOWERS DOSE TO HEART AND LUNGS IN EARLY-STAGE HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE.
Published in:
Hematological Oncology, 2017, v. 35, p. 175, doi. 10.1002/hon.2438_36
By:
- Yang, J.C.;
- Kumar, A.;
- Chapman, K.L.;
- Burleson, S.;
- Huang, C.;
- Constine, L.S.;
- Hoppe, R.T.;
- Dandapani, S.;
- Straus, D.J.;
- Moskowitz, C.H.;
- Yahalom, J.
Publication type:
Article
PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY CLASSICAL HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF THE PHASE 2 KEYNOTE-087 STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 136, doi. 10.1002/hon.2437_125
By:
- Zinzani, P.L.;
- Fanale, M.A.;
- Chen, R.;
- Armand, P.;
- Johnson, N.;
- Brice, P.;
- Radford, J.;
- Ribrag, V.;
- Molin, D.;
- Vassilakopoulos, T.P.;
- Tomita, A.;
- Tresckow, B.;
- Shipp, M.A.;
- Zhang, Y.;
- Balakumaran, A.;
- Moskowitz, C.H.
Publication type:
Article
PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA ( RRPMBCL): UPDATED RESULTS FROM THE KEYNOTE-013 TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 189, doi. 10.1002/hon.2438_50
By:
- Zinzani, P.;
- Ribrag, V.;
- Moskowitz, C.H.;
- Michot, J.;
- Kuruvilla, J.;
- Bartlett, N.;
- Balakumaran, A.;
- Chatterjee, A.;
- Chlosta, S.;
- Shipp, M.A.;
- Armand, P.
Publication type:
Article
TIME FROM DIAGNOSIS TO 2ND TREATMENT IS A PROMISING SURROGATE FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 230, doi. 10.1002/hon.2438_93
By:
- Soumerai, J.D.;
- Ni, A.;
- Batlevi, C.;
- Alperovich, A.;
- Bantilan, K.S.;
- Palomba, M.;
- Gerecitano, J.F.;
- Noy, A.;
- Hamlin, P.;
- Moskowitz, C.H.;
- Copeland, A.R.;
- Matasar, M.J.;
- Drullinsky, P.R.;
- Hamilton, A.;
- Horwitz, S.M.;
- Intlekofer, A.M.;
- Kumar, A.;
- Moskowitz, A.;
- Portlock, C.;
- Sauter, C.
Publication type:
Article

Found: 11